JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopman, A. F.
Right arrow Articles by Malik, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopman, A. F.
Right arrow Articles by Malik, R.
Related Collections
Right arrow Pharmacology

Anesth Analg 2005;100:1343-1347
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000148076.17331.51

ANESTHETIC PHARMACOLOGY

The Effect of Nitrous Oxide on the Dose-Response Relationship of Rocuronium

Aaron F. Kopman, MD*, Wanda A. Chin, MD{dagger}, Jimmy Moe, MD{dagger}, and Rawshan Malik, MD{dagger}

Departments of Anesthesiology, *New York Medical College, Valhalla; and {dagger}Saint Vincent’s Hospital Manhattan, New York City, New York

Address correspondence to Aaron F. Kopman, MD, Department of Anesthesiology, Room N.R. 408, St. Vincent’s Hospital Manhattan, 170 West 12th St., New York City, NY 10011. Address e-mail to akopman{at}nyc.rr.com.

It has been generally assumed that nitrous oxide (N2O) enhances the effects of nondepolarizing muscle relaxants only weakly if at all. More recent evidence suggests that drug potency may be more intense under N2O anesthesia compared with total IV anesthesia (TIVA). However, the magnitude of this effect has not been well defined. We measured the 50% effective dose of rocuronium in 35 patients receiving N2O-propofol-opioid anesthesia and a comparable group receiving TIVA. A single dose of rocuronium was given to each patient and drug potency was calculated for each individual from the Hill equation assuming a log-dose/logit slope of 4.5. In both groups, the relaxant was administered 15 min after induction of anesthesia. Neuromuscular function was measured using electromyography with single stimuli at 0.10 Hz. We measured a 50% effective dose of 0.209 ± 0.051 mg/kg during TIVA and of 0.166 ± 0.041 mg/kg during N2O anesthesia, a decrease of 20% (P < 0.001). The clinical importance of this effect must be considered modest; however, estimates of potency that are usually obtained during N2O anesthesia may underestimate drug requirements at the time of induction of anesthesia.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.